{"data":{"type":"company_profile_ai","id":180147,"entity_id":"wefunder:company:180147","attributes":{"canonical_url":"https://wefunder.com/sunstone.health","retrieval_urls":{"canonical":"https://wefunder.com/sunstone.health","json":"https://wefunder.com/sunstone.health.json","markdown":"https://wefunder.com/sunstone.health.md","ai_json":"https://wefunder.com/sunstone.health.ai.json","ai_text":"https://wefunder.com/sunstone.health.ai.txt","changelog_json":"https://wefunder.com/sunstone.health.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-04T21:34:50Z","generated_at":"2026-06-05T02:46:41Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":180147,"entity_id":"wefunder:company:180147","slug":"sunstone.health","name":"Sunstone Health","tagline":"AI-powered precision health platform for kids with genetic diseases. ","location":"Boston, MA","website":"https://www.sunstonehealth.com","total_amount_raised":1658634,"total_investors":886,"is_funded":true,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 1658634","citation":"https://wefunder.com/sunstone.health#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:46:41Z","confidence":"high"},"observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-05T21:34:50Z"},{"claim_id":"claim-total-investors","text":"Total investors: 886","citation":"https://wefunder.com/sunstone.health#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:46:41Z","confidence":"high"},"observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-05T21:34:50Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 1658634","citation":"https://wefunder.com/sunstone.health#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:46:41Z","confidence":"high"},"observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-05T21:34:50Z"},{"claim_id":"claim-total-investors","text":"Total investors: 886","citation":"https://wefunder.com/sunstone.health#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:46:41Z","confidence":"high"},"observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-05T21:34:50Z"}],"company_claims":{"tagline":"AI-powered precision health platform for kids with genetic diseases. ","story":"AI to Power the Healthcare Revolution1 in 31 kids has autism. In today's system, the path to a genetic answer takes years. With Sunstone's AI, it's 12 weeks.$1M left to close our Series A. $8.5M valuation set by Saturn Partners. 6.5M+ lives in our pipeline. Pilots live now.What we do.We end the diagnostic odyssey — years of wrong specialists, wrong tests, and wrong treatment. It's the single biggest cost sink in genetic disease.How we do it.We sell self-insured employers a benefit for their employees' families.Our AI finds the kids in the claims data. Broad Clinical Labs sequences their genome. Our doctors deliver a plan to their doctor.12 weeks, end to end. Not 7 years.Why autism is broken.1 in 31 kids. ABA therapy costs employers $40K–$60K per child per year.Autism is deeply genetic. About 30% of cases have an identifiable genetic cause today, and that number grows every year as the science improves. But fewer than 20% of kids with autism ever get a genetic test — even though every major pediatric board recommends it.So therapy gets built on guesswork. A child gets the wrong care for years. One undiagnosed case can cost $3.1M over a lifetime.The kids are in the data. Nobody is looking.Christopher. Age 7.Before Sunstone: 40 hours of therapy a week. No plan. No genetic test. $58,400/year.After Sunstone: Fragile X found. Therapy rebuilt around it. Real progress in 6 months. $21,200/year.64% less money. A child with a plan. A family with answers.How we make money.$10,000 per case we solve. Flat fee. Paid only after we deliver the doctor-to-doctor care plan.One case that breaches a $250K stop-loss = 25× ROI. And the employee gets something priceless: real answers for their kid.60%+ gross margin at scale.Autism today. Every genetic disease tomorrow.We start with autism — the pain is real, the market is big, the genetics are clear.Then: pediatric epilepsy. Rare disease. Adult genetic conditions. The identification layer we build for autism becomes the layer for every genetic disease in employer health plans.Where we are.6.5M+ lives in active pipelineFortune 50 telecom — NDA signed, principal benefits buyerNational grocery chain — pilot explorationCare management platform — 200K lives, contract finalizationBroad Clinical Labs — signed lab deal with the institution behind the Human Genome ProjectAdvisors from Mass General Brigham, Medco, Illumina, Proteus, Alva10We have contracts on the table.Why I built this.I'm Joshua. Biomedical engineer, Harvard-trained. My son has PFAPA — a rare autoimmune condition with no treatment.I know what the system does to families who don't fit its script. I lived it.So I built what we all needed.The round. Raising$1M to closePre-money$8.5M — Saturn Partners, 1× prefRevenuePay-for-results — only on deliveryUse of fundsClose pilots, scale ops, launch 1/1/27Why community.We could have closed this with institutions. We chose you.Because the people who understand why Sunstone matters are the ones who've lived it. Parents. Clinicians. Benefits pros. Anyone who's watched the system fail a kid.We want you in. Not for the check. For the army.Startup investing is risky. You may lose your entire investment. See Form C on Wefunder for full terms.","quick_facts":["Reduces 7-year diagnostic odyssey into a 12-week precision care solution","Proven with \u0026gt;400 families, 90% opt-in, active with major US health plans","AI powered pattern recognition finds kids with genetic diseases in claims data","First-to-market, trade-secret and method-patented model built for scale","Partnered with NVIDIA Inception Program, Creative Destruction Lab Computational Health Cohort 2024","Backed by team of Advisors and Investors with Billions in successful exits"]},"computed_metrics":{"total_amount_raised":1658634,"total_investors":886,"team_size":8,"featured_investor_count":4,"faq_count":5,"recent_post_count":3},"quick_facts":[{"claim_id":"claim-fact-1","value":"Reduces 7-year diagnostic odyssey into a 12-week precision care solution","citation":"https://wefunder.com/sunstone.health#claim-fact-1","observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-11T21:34:50Z"},{"claim_id":"claim-fact-2","value":"Proven with \u0026gt;400 families, 90% opt-in, active with major US health plans","citation":"https://wefunder.com/sunstone.health#claim-fact-2","observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-11T21:34:50Z"},{"claim_id":"claim-fact-3","value":"AI powered pattern recognition finds kids with genetic diseases in claims data","citation":"https://wefunder.com/sunstone.health#claim-fact-3","observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-11T21:34:50Z"},{"claim_id":"claim-fact-4","value":"First-to-market, trade-secret and method-patented model built for scale","citation":"https://wefunder.com/sunstone.health#claim-fact-4","observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-11T21:34:50Z"},{"claim_id":"claim-fact-5","value":"Partnered with NVIDIA Inception Program, Creative Destruction Lab Computational Health Cohort 2024","citation":"https://wefunder.com/sunstone.health#claim-fact-5","observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-11T21:34:50Z"},{"claim_id":"claim-fact-6","value":"Backed by team of Advisors and Investors with Billions in successful exits","citation":"https://wefunder.com/sunstone.health#claim-fact-6","observed_at":"2026-06-04T21:34:50Z","expires_at":"2026-06-11T21:34:50Z"}],"latest_fundraise":{"id":140199,"entity_id":"wefunder:fundraise:140199","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[],"team":[{"id":6593362,"entity_id":"wefunder:company_role:6593362","name":"Joshua Resnikoff","title":"CEO + Cofounder","role":"founder","profile_url":"https://wefunder.com/joshua.resnikoff.2"},{"id":5671536,"entity_id":"wefunder:company_role:5671536","name":"Calum MacRae","title":"Head of Innovation","role":"employee"},{"id":5671543,"entity_id":"wefunder:company_role:5671543","name":"Sofia Giraldo","title":"Director of Operations","role":"employee","profile_url":"https://wefunder.com/sofia.giraldo"},{"id":6558311,"entity_id":"wefunder:company_role:6558311","name":"Paterson Anaccius","title":"Lead Full Stack Developer","role":"employee"},{"id":6558313,"entity_id":"wefunder:company_role:6558313","name":"Jonathan Calixte","title":"Full Stack Developer","role":"employee","profile_url":"https://wefunder.com/jonathan.calixte"},{"id":6558314,"entity_id":"wefunder:company_role:6558314","name":"Cameron Pearson","title":"Automation Architect","role":"employee"},{"id":5671533,"entity_id":"wefunder:company_role:5671533","name":"Martin Grasso","title":"CCO + Cofounder","role":"founder","profile_url":"https://wefunder.com/martin.grasso"},{"id":5672503,"entity_id":"wefunder:company_role:5672503","name":"Dr. Javier Romero","title":"Lead Medical Advisor","role":"employee"}],"featured_investors":[{"id":12748,"entity_id":"wefunder:company_investor_profile:12748","name":"Kingscrowd Capital","bio":"Kingscrowd Capital is the first Data-Driven Fund in the Online Private Market.","profile_url":"https://wefunder.com/kingscrowd.capital.3","endorsement_quote":"TMA is tackling a large and painful problem with a differentiated solution, strong early validation, and a capable team. At its current valuation, we view this as a compelling entry point for KC Capital. We are excited to join TMA Precision Health as it works to become a leader in AI-enabled precision medicine for genetic disease patients."},{"id":11526,"entity_id":"wefunder:company_investor_profile:11526","name":"Saturn Investment Partners","bio":"Saturn Partners has a seasoned, cohesive investment team with specialized expertise in managing, advising and investing in early-stage companies. Each of our portfolio companies benefits from the attention and expertise of our entire team, not just one partner. We all share one goal: creating substantial value for investors while helping smart entrepreneurs solve some of the world’s biggest challenges.","profile_url":"https://wefunder.com/saturn.investment.partners","endorsement_quote":"Saturn is thrilled to participate in this Series A round because we firmly believe the future of medicine is in the use of genomics in bringing precision medicine to drive real value for health plans and into the healthcare ecosystem at large."},{"id":11527,"entity_id":"wefunder:company_investor_profile:11527","name":"Henry Albrecht","bio":"Henry Albrecht is the founder and former CEO of Limeade, an employee well-being and experience SaaS company he started in 2006 and grew from a basement idea into a $60M-revenue public company, ultimately acquired by WebMD. At Limeade, he helped define the future of work by building the #1 Best Company to Work For in Washington and earning recognition such as EY Entrepreneur of the Year, and he now serves as a board director, advisor, and mentor to disruptive companies and their CEOs.","profile_url":"https://wefunder.com/henry.albrecht","endorsement_quote":"I invested in TMA because Josh and his team combine a rare, human-centered mission with a precision-health platform that’s designed to scale. They’re solving a problem that deeply affects families today while opening a massive opportunity to transform how payers care for complex patients. That combination of purpose and market readiness is exactly what I look for."},{"id":12775,"entity_id":"wefunder:company_investor_profile:12775","name":"Alan Sakowitz","bio":"Alan Sakowitz is the CEO of Pointe Development Company, a seasoned real-estate developer, attorney, author, and early-stage investor renowned for his disciplined approach to value creation and unwavering commitment to ethical leadership. With more than three decades of experience in real estate development, law, financing, and asset management, Alan has successfully led complex commercial and residential projects across multiple markets. A graduate of the University of Miami School of Law, he holds both a JD and an LLM in federal taxation. Alan is also the author of Miles Away… Worlds Apart, a widely recognized book that details his pivotal role in exposing one of Florida’s largest Ponzi schemes. Today, as an active angel investor, Alan brings founders a distinctive blend of legal expertise, operational insight, and principled, long-term support—making him a trusted partner for mission-driven companies.","profile_url":"https://wefunder.com/alan.sakowitz","endorsement_quote":"Upon speaking with Joshua Resnikoff, we were impressed by his clear communication, ability to build and manage a seamless process, and strong leadership. These personal impressions led us to invest. TMA Precision Health’s model is designed to create a strong alignment of interests: a win-win-win-win for insurers/employers, patients, families, and TMA itself. The structure—where TMA is paid only upon successfully helping the insured—turns the program into real savings rather than an added expense for payers, which could significantly reduce sales friction and incentivize referrals. The use of AI to enable a lean team to deliver high-level service at low cost, with apparent scalability and minimal marginal cost per case, struck us as compelling. Most importantly, the possibility of identifying life-changing medical solutions in weeks rather than years will provide patients and families with both cost savings and genuine peace of mind and hope. It’s rare to find a company that is both commercially powerful and profoundly impactful for society. We believe TMA does both and, therefore, we are proud to be a lead investor in this round and look forward to TMA’s continued growth and success."}],"relationships":[{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:user:4995598","target_url":"https://wefunder.com/joshua.resnikoff.2"},{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:company_role:5671536"},{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:user:4767579","target_url":"https://wefunder.com/sofia.giraldo"},{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:company_role:6558311"},{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:user:4992331","target_url":"https://wefunder.com/jonathan.calixte"},{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:company_role:6558314"},{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:user:4752457","target_url":"https://wefunder.com/martin.grasso"},{"source_entity_id":"wefunder:company:180147","relation":"has_team_member","target_entity_id":"wefunder:company_role:5672503"},{"source_entity_id":"wefunder:company:180147","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:12685","target_url":"https://wefunder.com/kingscrowd.capital.3"},{"source_entity_id":"wefunder:company:180147","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:15276","target_url":"https://wefunder.com/saturn.investment.partners"},{"source_entity_id":"wefunder:company:180147","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:15275","target_url":"https://wefunder.com/henry.albrecht"},{"source_entity_id":"wefunder:company:180147","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:16609","target_url":"https://wefunder.com/alan.sakowitz"},{"source_entity_id":"wefunder:company:180147","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:300892","target_url":"https://wefunder.com/feed/300892"},{"source_entity_id":"wefunder:company:180147","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:263287","target_url":"https://wefunder.com/feed/263287"},{"source_entity_id":"wefunder:company:180147","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:262889","target_url":"https://wefunder.com/feed/262889"},{"source_entity_id":"wefunder:company:180147","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:140199"}],"faq":[{"question":"Your program sounds impressive and seems like a win-win-win for all involved. I have a few clarifying questions: The overview mentions a raise of $5M, but the top section lists a goal of $3.59M. Is there a discrepancy, or am I misinterpreting something? What is the exit strate...","answer":"Hi Alan and Leah - Thank you for your interest! We have worked extremely hard to make sure all parties win to drive adoption and scale. I have added additional clarifying information to the documentation and had Wefunder correct the displayed goal, apologies for the confusion. The full Series A round is for $5M. We have set aside $400,000 for our community to engage through Wefunder (with the remainder in discussion with other strategic and/or institutional investors). Our lead investor Satur..."},{"question":"hOW MUCH IS A SHARE WORTH NOW, TODAY?","answer":"$0.9034"},{"question":"I came across your Crowdfunding campaign on Wefunder and wanted to reach out. The Backer Hive is an invite-only club for serious backers interested in crowdfunding campaigns. With over 300k subscribers to our newsletter, we offer excellent rates to help promote your project th...","answer":"Thanks Saheed"},{"question":"I came across your Crowdfunding campaign on Wefunder and wanted to reach out. The Backer Hive is an invite-only club for serious backers interested in crowdfunding campaigns. With over 300k subscribers to our newsletter, we offer excellent rates to help promote your project th...","answer":"Thanks Saheed"},{"question":"I and interested, but have 2 quick questions. 1. Are we buying shares in this round, or it's simply pre-money SAFE which leads to per % of ownerships? 2. When was the company founded, and how much revenue so far?","answer":"Thanks for your interest Yubing! The company was founded at the end of 2019 and we spent a few years doing research and running a pilot out of Medellin Colombia. In 2023 we took the lessons and data we developed to reorganize as a scalable, software first platform, and starting actively selling to self-funded health plans in Q4 2024. We are currently pre-revenue, but have contracts that represent ~250,000 lives, and have a $2.3M revenue horizon for 2025. You are buying Series A preferred shar..."}],"recent_posts":[{"id":300892,"entity_id":"wefunder:feed_item:300892","title":"Heads Down, Moving Forward.","preview":"Our community round is open through April 30, 2026 — 15 days leftHi Sunstone community —It's been a minute since you've heard from me — that's because we've been heads down, deep in the work. This is the busy season for us — we're in active conversations, we're at conferences, and we're building every day.Wanted to pop in and just say — thank you. You've helped us raise $3,936,676 in our Series A, and that means everything to this team.Quick reminder: our round closes April 30th. If you've be...","published_at":"2026-04-15T17:14:51Z","canonical_url":"https://wefunder.com/feed/300892"},{"id":263287,"entity_id":"wefunder:feed_item:263287","title":"Sunstone in Reuters!","preview":"This week, Reuters ran a piece on Sunstone and on the problem we are built to fix: families with genetic disease get stuck in a system that moves slowly, pays late, and often leaves parents doing the coordination work themselves.What I like about this article is that it puts a spotlight on the real issue, incentives. Most plans are built around short time horizons, so early action is deprioritized even when it is the right clinical move and the smart economic move. When a child is waiting for...","published_at":"2026-02-20T16:24:48Z","canonical_url":"https://wefunder.com/feed/263287"},{"id":262889,"entity_id":"wefunder:feed_item:262889","title":"March 4 - Community Update","preview":"We moved the community session to March 4 at noon ET.I want to use that time to walk through what has actually changed since we moved from TMA to Sunstone, what our commercial pipeline looks like right now, and how we are positioning ourselves in the stop-loss and employer markets.This is a straight update for the people who have backed us and the people thinking seriously about backing us.If you want to understand how we are thinking about the next stage and what the actual strategy looks li...","published_at":"2026-02-19T22:24:25Z","canonical_url":"https://wefunder.com/feed/262889"}],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-05T02:46:41Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:46:41Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T21:34:50Z","as_of":"2026-06-05T02:46:41Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-05-01T05:06:56Z","as_of":"2026-06-05T02:46:41Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-05-01T05:06:56Z","as_of":"2026-06-05T02:46:41Z","confidence":"medium"}}}}}}